Skip to content

PULSE PROTEIN

Active
Private limited companyfounded 20251 year activeSint-Lambertusstraat 135, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 1024.526.173
Summary

PULSE PROTEIN has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.0m and a net result of -€64,492. Its solvency ranks better than 83% of 22,158 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Other non-specialised retail sale
NACE 47120Intermediation services for non-specialised retail NACE 47910
2 sites
Size
€1.4mtotal assets 2025
Equity
€1.0m
Loss
-€64,492
Turnover not published (abridged schema)
Financial health
84 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Parent
VITALIX LAB · 74.4%
Board
4 members
Accounts filed 48 days late2 of 3 deeds read
Why 84- Latest accounts 48 days late; 1 of the last 3 late- Founded in 2025+ Liquidity: current ratio 3.87, cash €479,904+ Size: total assets €1.4mShow the evidence

Checked score

Score 2025
84 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 63% of its sector peers (NACE 47, micro)
Financial strength
Strong
Solvency 100
equity 74.6% of total assets
Liquidity 83
short-term debt 25.4% · cash 34.5%
Profitability 13
return on assets -4.6%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,169 companies)
Last 24 months 07-2026: 2.2% 08-2026: 2.2%● unchanged vs 07-2026 09-2026: 2.3%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.4%▼ -1.9 percentage points vs 09-2026lowest value
Credit up to €85,000 at 30 days only on tighter terms
Liquidity ample (current ratio 3.87; short-term debt: 25.4% and cash: 34.5% of total assets), and 25.4% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 84% on solvency, 87% on liquidity and 18% on profitability.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 3.87, cash €479,904
NBB · annual accounts
raises risk · Latest accounts 48 days late; 1 of the last 3 late
NBB · filings
raises risk · Founded in 2025
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Size: total assets €1.4m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-09-2026, 48 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
48 days late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Resignation: Amandine de Paepe (director)State Gazette act
  2. Annual accounts filedfiscal year 2025 · micro…
  3. Resignation: Vitalix Lab SRL (director)Permanent representatives: Alain ETIENNE and…

Key points

  • Caution: Among the weakest 5% on net resultsector median €5,032 · 22,136 companies -€64,492 View
  • Board changedlatest change 28-09-2026 · 4 in office 4 joined · 2 left View
  • Founded 15 months agofounded 20-06-2025 15 months View
  • Controlled by VITALIX LAB 74.4% View

By topic

Financials

Fiscal year
2025
Total assets
€1.4m
Loss
-€64,492
Solvency
74.6%
Go to Financials

Board & ownership

Board
4 members
Parent
VITALIX LAB · 74.4%
  • Alain ETIENNEDirector
  • Emna EVERARDDirector
  • SOCIETE DE SERVICES, DE PARTICIPATIONS, DE DIRECTION ET D'ELABORATIONDirector
  • Xavier Van CampenhoutDirector
Go to Board & ownership

Company details

Sites
2
Legal form
Private limited company
Activity
Other non-specialised retail saleNACE 47120
Founded
20-06-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
6
Purpose
La production,la transformation,le conditionnement et la commercialisation de produits…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.